buntanetap/posiphen

Drug identity checked against registry records

Also recorded as ANVS401; Posiphen Tartrate

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Buntanetap in Participants With PDNCT07284784ANVSPhase 2, Phase 3Recruiting2029-09Estimated
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDNCT05357989ANVSPhase 3Completed2023-12-04Actual
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADNCT06709014ANVSPhase 3Active not recruiting2027-12Estimated
An Open-label Long-term Safety Study of Buntanetap in Participants With ADNCT07757204ANVSPhase 2, Phase 3Not yet recruiting2030-02-21Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.